期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

罗红霉素治疗冠心病的疗效观察 被引量：1

Therapeutic effect of Roxithromycin in coronary artery disease
下载PDF
导出
摘要 目的:探讨罗红霉素在冠心病治疗中的作用。方法:选择符合冠心病诊断标准的60例血肺炎衣原体抗体IgG阳性患者,采用随机方法均分为罗红霉索治疗组及对照组,1个月后治疗组复查血肺炎衣原体抗体IgG,随访1年。结果:罗红霉素治疗组,3例出现心血管事件,发生率10％,对照组10例出现心血管事件,发生率33.3％,罗红霉素治疗组心血管事件发生率明显低于对照组(P<0.05),两组治疗前,治疗组治疗前、后肺炎衣原体抗体IgG滴度比较差异无显著性。结论:罗红霉素能减少冠心病心血管事件发生率。 Objective: To explore the therapeutic effect of Roxithromycin in coronary artery disease (CAD). Methods: A total of 60 CAD patients with IgM antibody positive of chlamydia pneumoniae(Cp) were divided into Roxithromycin group (30 cases, treated with Roxithromycin 150 mg, bid) and control group (30 cases, no treated with Roxithromycin). IgM antibody of Cp was re-examined after therapy one month. The patients were followed up one year. Results: There were 3 cases (10%) occurred with events of cardiovascular in Roxithromycin group, but it were 10 cases (33%) in control group. Incidence of cardiovascular events of Roxithromycin group was less than control group (P<0. 05). Tilers of Cp were no significantly difference between two groups before and after therapy. Conclusion: Roxithromycin can decrease the incidence of cardiovascular events in CAD patients.
作者 王芬珍 江挺 吴炳元 叶榕 卓闽彬 费正芳
机构地区 福州市第一医院
出处 《心血管康复医学杂志》 CAS 2004年第6期542-544,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 罗红霉素 治疗组 冠心病 心血管事件 发生率 肺炎衣原体抗体 对照组 治疗前 疗效观察 治疗中 Roxithromycin Coronary artery disease (CAD) Chlamydia pneumoniae (Cp)
分类号 R541.4 [医药卫生—心血管疾病] R554.6 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献9

二级参考文献29

  • 1倪安平,王辉,董平,李永哲,王仲,朱元珏.肺炎、支气管炎和急性上呼吸道感染患者肺炎衣原体感染的研究[J].中华内科杂志,1995,34(6):388-391. 被引量：45
  • 2[1]Grayston JT, Kuo CC, Campbell LA, et al. Chlamydia pneumoniae sp. nov. for Chlamydia, Strain TWAR [J]. Iht J Syst Bacteriol,1989, 39 (1): 88.
  • 3[2]Saikku P, Mattila K, Nieminen HS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic cornary heart disease and acute myocardial infarction [J]. Lancet,1988, 2 (Dct 29): 983.
  • 4[3]Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries [J]. J Infect Dis, 1993, 167 (4): 841.
  • 5[4]Kuo CC, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) [J]. Clin Microbiol Rev, 1995, 8: 451.
  • 6[5]Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovasular events, and azithromycin in male survivors of myocardial infarction [J]. Circulation, 1997,96:404.
  • 7[1]Kristensen SD,Ravn HB,Falk E.Insight into the pathophysiology of unstable coronary artery disease[J].Am J Cardiol,1997,80(5A): 5-9.
  • 8[2]Vercellotti C.Infectious agents that play a role in atherosclerosis and vasculopathies,What are they? What do we do about them[J].Can J Cardiol,l999,l5(Suppl B): 13-15.
  • 9[3]Jackson LA,Campbell LA,Kuo CC,et al.Isolation of Chla-mydia pneumoniae from a carotid endarterectomy specimen[J].J Infect Dis,1997,176(1): 292-295.
  • 10[4]Anon.Randomised trial of roxithromycin in non-Q-wave coronary syndromes.ROXIS pilot study[J].Lancet,1997,350(75): 404-407.

共引文献32

同被引文献12

  • 1张金枝.冠心病的新候选危险因子[J].心血管康复医学杂志,2003,12(z1):496-499. 被引量：21
  • 2Folsom AR,Nieto FJ,Sorli e P,et al.Holicobater pylori seropositivity and coronary heart disease inciden ce[J].Circulation,1998,98(9):845-850.
  • 3Chiu B,Viira E,Tucker W ,et al.Chlmydia pneumoniae,cytomegalovirus and herpes simplex virus in ather osclerosis of the coronary artery[J].Circulation,1997,96(7):2144-2148.
  • 4Sinisalo J,Kimmo Mattilak.Effect of 3 months of antimicrobial treatme nt with clarithromycin in acute non-Q-wave coronary syndrome[J].Circulation ,2002,105:1555-1559.
  • 5Gupta S,Leatham EW,Carrington D,et al.Elevated chlamydia pneumoni a e antibodies cardiovasular events and azithromycine in male survivors of acute m yocardial infarction[J].Circulation,1997,96(2)404-407.
  • 6Gurfinek IE,Bozovich G,Beckt E,et al.Treatment with the antibiotic ro xithromycin in patient with non-Q-wave coronary syndromes[J].Eur Heart J, 1999,20(2):121-127.
  • 7Zeiher AM,Geobe l H,Schachinger V,et al.Tissue endothelin-1 immunoreactivity in the acute corona ry atherosclerotic plapue.A clue to the mechanism of transformation from the sta ble to unstable clinic state[J].Circulation,1995,91(4):941-947.
  • 8Ja ckson LA,Campbell LA,Kuo CC,et al.Isolation of chlamydial pneumoniae from a carotid endarterecotmy specimen[J].J Infect Dis,1997,176(1):292-295.
  • 9Davidson M,Kuo CC,Middaugh JP,et al.Confirmed previous infection with chlamydiae pneumoniae(TWAR) and its presence in early coronaryatherosclerosis[J].Circulation,1998,98(7):628-633.
  • 10Melnick JL,Adam E,Debakey ME,et al.Possible role of cytomegalovirus i n atherogensis[J].JAMA,1990,263(16):2204.

引证文献1

心血管康复医学杂志
2004年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部